For instance, Peng et al. found that activated NF-κB signaling results in TSCC cell resistance to chemotherapy and promotes cell survival, while inhibition of NF-κB signaling dramatically reduces the proliferation of oral squamous cell carcinoma [11]. Here, NFKB1 is linked to oral cavity squamous cell carcinoma.